Archives

by in
Entry Author Date Location
Igenica Follows Genentech Into Antibody-Linked Cancer Drugs 04/11/14 San Francisco
Igenica Lands $14,000,000 Series C Financing Round 01/28/14 San Francisco
Immune Design Grabs $32.5M, Cashing in on Cancer Immunotherapy Rush 10/30/13 Seattle
Immune Design Garners $49,000,000 Series C Financing 10/30/13 Seattle
Seragon Pharmaceuticals Obtains $30,000,000 Series A Financing 10/18/13 San Diego
NGM, Partners Seek Next Diabetes Drug Targets Among GI Tract Hormones 06/25/13 San Francisco
Immune Design, NY Non-Profits Team Up to Boost Cancer Drugs 06/12/13 Seattle
San Diego Life Sciences Roundup: Regulus, Aragon, Cytori, & More 10/05/12 San Diego
Aragon Pharmaceuticals Receives $49,999,988 Series D Round 09/26/12 San Diego
Who’s Still Active Among the Early-Stage Biotech VCs? 07/02/12 National
Igenica Pulls in $33M to Fight Cancer With Antibodies 06/12/12 San Francisco
Igenica Garners $33,000,000 Series C Financing Round 06/12/12 San Francisco
Nurix Garners $3,100,000 New Funding Round 05/17/12 San Francisco
Targeted Cancer Drugs With Punch: The Next Big Class of Antibodies 05/16/12 National
Aragon Pharmaceuticals Obtains $42,000,000 Series C Financing Round 03/06/12 San Diego
Genentech Pours $95M Into Constellation’s Drug Platform 01/17/12 Boston
Biotech VCs Have a Problem, and it Will Get Worse Before It Gets Better 10/24/11 National
Light Sciences Stumbles, Cardiac Dimensions Gets EU OK, Immune Design Pockets $11M, & More Seattle-Area Life Sciences News 10/06/11 Seattle
Immune Design Rakes In Another $11M From Prior VC Round 10/05/11 Seattle
Peloton Therapeutics Lands $18,000,000 Series A Financing Round 07/27/11 San Francisco
Peloton Therapeutics Secures $18,000,000 Series A Funding 07/27/11 Texas
Cyterix Develops New Twist on an Old Idea, With ‘Smart Bomb’ Cancer Drugs 06/22/11 San Francisco
Constellation Pharma Raises More Money and Further Defines Pipeline 06/17/11 Boston
Aria Shows Drug Data at ASCO, Pfizer Supports Selecta, WPI Adds Big Pharma Partners, & More Boston-Area Life Sciences News 06/10/11 Boston
General Compression Pulls In $20.4M, Constellation Nabs $15M, PolyRemedy Wraps Up $20M, & More Boston-Area Deals News 06/08/11 Boston
Cyterix Pharmaceuticals Receives $9,200,000 Series A Funding Round 06/08/11 San Francisco
Cyterix Raises $9.2M for Cancer Drugs 06/07/11 San Francisco
Constellation Pharma Raises $15M for Epigenetic Drugs 06/06/11 Boston
Constellation Pharmaceuticals Garners $15,000,000 Series B Funding 06/06/11 Boston
Immune Design, Developer of New Vaccines, Adds Former Elan President as New CEO 04/27/11 Seattle
Page 1 of 2 next page »